Diabetes Care
Freestyle Libre CGM technology is leading with heart
FreeStyle Libre technology is linked with fewer hospitalizations for heart issues.
We'll design our technologies and products for broader access and affordability at every step – from every phase of our R&D process, to the materials we use, to manufacturing, to the ways we reach the people who need them.
Across our business and through collaboration, we'll create new technologies and find new answers for chronic health conditions like diabetes and cardiovascular disease, malnutrition, and infectious diseases such as COVID-19, HIV, malaria and hepatitis, as well as tomorrow's pandemic threats.
We will work side-by-side with people and communities we serve, partners, governments and other stakeholders to address health disparities, expand access and remove barriers that prevent people from living healthy lives, wherever they are.
Our 2030 targets
New ideas come from different places and points of view. To achieve our ambitions, we're actively shaping our organization for the future by advancing STEM education and internships, and empowering our teams with skills to meet the health needs of tomorrow.
Our data insights and connected technologies help people and their doctors make better, faster and more complete decisions about their health in ways that fit easily into their lives. Just as important, we protect our patients and customers through secure and responsible data collection.
We're building a more resilient supply chain, including working to expand opportunities and actively engaging with suppliers to meet our high quality standards.
We're working across our operations and with key suppliers to sustainably manage our water use and address climate change by reducing carbon emissions and expanding renewable energy. And we'll reduce the environmental impact of our product packaging and minimize waste in our operations through reuse and recycling programs across our company.